Vaxil Bio Ltd. (VXL.V)
0.145
0.00 (0.00%)
CAD |
TSXV |
Oct 13, 16:00
Vaxil Bio Net Income (Quarterly) : -0.064M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.064M |
| March 31, 2026 | -0.107M |
| December 31, 2025 | 0.567M |
| September 30, 2025 | -0.02M |
| June 30, 2025 | 0.036M |
| March 31, 2025 | -0.07M |
| December 31, 2024 | 0.00 |
| September 30, 2024 | -0.036M |
| June 30, 2024 | -0.042M |
| March 31, 2024 | -0.058M |
| December 31, 2023 | 0.026M |
| September 30, 2023 | -0.028M |
| June 30, 2023 | -0.127M |
| March 31, 2023 | -0.125M |
| December 31, 2022 | -0.173M |
| September 30, 2022 | -0.139M |
| June 30, 2022 | -0.146M |
| March 31, 2022 | -0.126M |
| December 31, 2021 | -0.28M |
| September 30, 2021 | -0.239M |
| June 30, 2021 | -0.209M |
| March 31, 2021 | -0.258M |
| December 31, 2020 | -0.575M |
| September 30, 2020 | -0.313M |
| June 30, 2020 | -0.297M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.173M |
| December 31, 2019 | -0.492M |
| September 30, 2019 | -0.207M |
| June 30, 2019 | -0.203M |
| March 31, 2019 | -0.252M |
| December 31, 2018 | -0.398M |
| September 30, 2018 | -0.23M |
| June 30, 2018 | -0.18M |
| March 31, 2018 | -0.239M |
| December 31, 2017 | -0.538M |
| September 30, 2017 | -0.336M |
| June 30, 2017 | -0.319M |
| March 31, 2017 | -0.605M |
| December 31, 2016 | -0.634M |
| September 30, 2016 | -0.293M |
| June 30, 2016 | -0.374M |
| March 31, 2016 | -3.238M |
| December 31, 2015 | -0.116M |
| September 30, 2015 | -0.274M |
| November 30, 2014 | -0.0348M |
| August 31, 2014 | -0.0366M |
| May 31, 2014 | -0.0766M |
| February 28, 2014 | -0.098M |
| November 30, 2013 | -0.1872M |
| August 31, 2013 | 0.0591M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Kane Biotech, Inc. | -0.8336M |
| Quest PharmaTech, Inc. | 3.401M |
| BriaCell Therapeutics Corp. | -9.920M |
| Waverley Pharma, Inc. | -0.1437M |
| Goldcoast Resource Corp. | -0.0999M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.064M |
| EPS Diluted (Quarterly) | -0.0161 |
| Enterprise Value | 0.1137M |
| Earnings Yield | 65.38% |
| Normalized Earnings Yield | -8.828 |